6.1 - 7.8

3.9 - 11.1

P

logistics

n

193

510

Age, median [Q1, Q3]

51.00 [40.00, 65.00]

54.00 [43.00, 65.00]

0.255

/

Male, n

114

307

0.796

/

Male, (%)

59.07%

60.20%

ethnicity

white, n

126

312

white, (%)

65.28%

61.18%

BLACK/AFRICAN AMERICAN, n

21

59

BLACK/AFRICAN AMERICAN, (%)

10.88%

11.57%

AMERICAN INDIAN/ALASKA NATIVE, n

0

2

AMERICAN INDIAN/ALASKA NATIVE, (%)

0.00%

0.39%

PORTUGUESE, n

2

4

PORTUGUESE, (%)

1.04%

0.78%

UNKNOWN, n

24

63

UNKNOWN, (%)

12.44%

12.35%

ASIAN, n

5

14

ASIAN, (%)

2.59%

2.75%

OTHER, n

7

21

OTHER, (%)

3.63%

4.12%

HISPANIC/LATINO, n

5

21

HISPANIC/LATINO, (%)

2.59%

4.12%

UNABLE TO OBTAIN, n

3

14

UNABLE TO OBTAIN, (%)

1.55%

2.75%

Aps III, median [Q1, Q3]

56.00 [40.00, 79.00]

59.00 [41.00, 84.00]

0.307

/

inSOFA, median [Q1, Q3]

1.00 [0, 3.00]

1.00 [0, 4.00]

0.410

/

▲SOFA, median [Q1, Q3]

1.00 [−1.00, 3.00]

1.00 [−1.00, 3.00]

0.769

/

Glu_meana (mmol/L), median [Q1, Q3]

6.90 [6.55, 7.38]

7.55 [6.42, 8.61]

<0.001*

/

Glu_cvb, median [Q1, Q3]

0.21 [0.16, 0.25]

0.22 [0.16, 0.31]

0.003

0.137

Glu_frequency* (n/day), median [Q1, Q3]

3.97 [2.58, 4.78]

4.43 [3.24, 6.10]

<0.001*

0.142

LOS in ICUc, median [Q1, Q3]

4.99 [3.09, 12.61]

4.95 [2.96, 11.67]

0.579

/

LOS in hospitald, median [Q1, Q3]

16.85 [10.62, 27.52]

16.62 [9.03, 26.71]

0.265

/

antibiotic day, median [Q1, Q3]

1.00 [0, 3.00]

1.00 [0, 3.00]

0.582

/

die, n

94

241

0.736

/

die, (%)

48.70%

47.25%

blood-infection, n

59

142

0.513

/

blood-infection, (%)

30.57%

27.84%

Abdominal-infection, n

24

71

0.711

/

Abdominal-infection, (%)

12.44%

13.92%

urinary-infection, n

20

57

0.892

/

urinary-infection, (%)

10.36%

11.18%

respiratory-infection, n

38

78

0.172

/

respiratory-infection, (%)

19.69%

15.29%

diabetes, n

25

148

<0.001*

0.002

diabetes, (%)

12.95%

29.02%

hypoglycemia, n

3

11

0.768

/

hypoglycemia, (%)

2.63%

3.58%

die, n

16

68

0.069

0.275

die, (%)

8.29%

13.33%

hyperlipidemia, n

29

96

0.2697

/

hyperlipidemia, (%)

25.44%

31.27%